Experimental evidence for growth factor treatment and function in certain neurological disorders.
This issue focuses on the potential utilization or involvement of growth factors in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, and epilepsy. Certainly, the role of growth factors in other neurological disorders associated with stroke, trauma, and neurodegeneration needs to be considered. While there is no direct evidence to indicate that a neurological disorder is associated with the compromised function of a specific growth factor, the use of these molecules as therapeutic agents is justifiable. Undoubtedly, the outcome of current clinical trials will certainly influence future decisions on the use of growth factor therapies.
Springer
J E
JE
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D006133:Growth Substances / Q000502:physiology* / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D006133:Growth Substances